Home NDC 69087-198-12 Jatenzo
Product NDC 69087-198
Requested package NDC 69087-198-12
11-digit product format 690870198
Labeler code 69087
Product ID 69087-198_0a548ae2-aa56-49bd-a339-a7b2b66fdb5c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name testosterone undecanoate
Dosage form CAPSULE, LIQUID FILLED
Route ORAL
Labeler TOLMAR Inc.
Application NDA206089
Marketing category NDA
Marketing start 2019-08-01
Substance TESTOSTERONE UNDECANOATE
Active strength 198 mg/1
Pharmacologic classes Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS]
DEA schedule CIII
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206089-001 JATENZO TESTOSTERONE UNDECANOATE 158MG CAPSULE / ORAL RLD 2019-03-27 N206089-002 JATENZO TESTOSTERONE UNDECANOATE 198MG CAPSULE / ORAL RLD 2019-03-27 N206089-003 JATENZO TESTOSTERONE UNDECANOATE 237MG CAPSULE / ORAL RLD, RS 2019-03-27
Orange Book patents# Current patent rows page 1 of 1 · 33 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206089-001 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 N206089-001 11331325 2027-01-06 U-2506 2022-06-02 N206089-001 8241664 2029-03-29 U-2506 Drug product 2019-04-08 N206089-001 10543219 2030-04-12 U-2506 2020-02-18 N206089-001 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 N206089-001 11179403 2030-04-12 U-2506 2021-12-21 N206089-001 11426416 2030-04-12 U-3420 2022-09-12 N206089-001 8778916 2030-04-12 Drug product 2019-04-08 N206089-001 8492369 2030-12-20 U-2506 Drug product 2019-04-08 N206089-001 11564933 2039-04-12 U-1103 2023-02-10 N206089-001 12605391 2039-04-12 U-1103 2026-04-24 N206089-002 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 N206089-002 11331325 2027-01-06 U-2506 2022-06-02 N206089-002 8241664 2029-03-29 U-2506 Drug product 2019-04-08 N206089-002 10543219 2030-04-12 U-2506 2020-02-18 N206089-002 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 N206089-002 11179403 2030-04-12 U-2506 2021-12-21 N206089-002 11426416 2030-04-12 U-3420 2022-09-12 N206089-002 8778916 2030-04-12 Drug product 2019-04-08 N206089-002 8492369 2030-12-20 U-2506 Drug product 2019-04-08 N206089-002 11564933 2039-04-12 U-1103 2023-02-10 N206089-002 12605391 2039-04-12 U-1103 2026-04-24 N206089-003 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 N206089-003 11331325 2027-01-06 U-2506 2022-06-02 N206089-003 8241664 2029-03-29 U-2506 Drug product 2019-04-08 N206089-003 10543219 2030-04-12 U-2506 2020-02-18 N206089-003 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 N206089-003 11179403 2030-04-12 U-2506 2021-12-21 N206089-003 11426416 2030-04-12 U-3420 2022-09-12 N206089-003 8778916 2030-04-12 Drug product 2019-04-08 N206089-003 8492369 2030-12-20 U-2506 Drug product 2019-04-08 N206089-003 11564933 2039-04-12 U-1103 2023-02-10 N206089-003 12605391 2039-04-12 U-1103 2026-04-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 132 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 c2088c7a36db…2026-09-14 22:38:34 2026-08 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 84e616aacf4f…2026-08-18 06:07:40 2026-07 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206089-002 JATENZO 198MG CAPSULE / ORAL RLD 2019-03-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N206089-003 JATENZO 237MG CAPSULE / ORAL RLD, RS 2019-03-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206089-001 JATENZO 158MG CAPSULE / ORAL RLD 2019-03-27 79d66fd596c7…
Observed Orange Book patent history# Patent history page 1 of 28 · 1,119 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-10-15 13:18:30 2026-09 N206089-001 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 11331325 2027-01-06 U-2506 2022-06-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 8241664 2029-03-29 U-2506 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 10543219 2030-04-12 U-2506 2020-02-18 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 11179403 2030-04-12 U-2506 2021-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 11426416 2030-04-12 U-3420 2022-09-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 8778916 2030-04-12 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 8492369 2030-12-20 U-2506 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 11564933 2039-04-12 U-1103 2023-02-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-001 12605391 2039-04-12 U-1103 2026-04-24 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 11331325 2027-01-06 U-2506 2022-06-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 8241664 2029-03-29 U-2506 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 10543219 2030-04-12 U-2506 2020-02-18 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 11179403 2030-04-12 U-2506 2021-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 11426416 2030-04-12 U-3420 2022-09-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 8778916 2030-04-12 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 8492369 2030-12-20 U-2506 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 11564933 2039-04-12 U-1103 2023-02-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-002 12605391 2039-04-12 U-1103 2026-04-24 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 11331325 2027-01-06 U-2506 2022-06-02 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 8241664 2029-03-29 U-2506 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 10543219 2030-04-12 U-2506 2020-02-18 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 11179403 2030-04-12 U-2506 2021-12-21 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 11426416 2030-04-12 U-3420 2022-09-12 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 8778916 2030-04-12 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 8492369 2030-12-20 U-2506 Drug product 2019-04-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 11564933 2039-04-12 U-1103 2023-02-10 c2088c7a36db…2026-10-15 13:18:30 2026-09 N206089-003 12605391 2039-04-12 U-1103 2026-04-24 c2088c7a36db…2026-09-14 22:38:34 2026-08 N206089-001 11179402 2026-04-14 Drug substance, Drug product 2021-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-001 11331325 2027-01-06 U-2506 2022-06-02 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-001 8241664 2029-03-29 U-2506 Drug product 2019-04-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-001 10543219 2030-04-12 U-2506 2020-02-18 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-001 10617696 2030-04-12 Drug substance, Drug product 2020-05-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-001 11179403 2030-04-12 U-2506 2021-12-21 84e616aacf4f…2026-09-14 22:38:34 2026-08 N206089-001 11426416 2030-04-12 U-3420 2022-09-12 84e616aacf4f…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 2 · 51 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Jatenzo
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TESTOSTERONE UNDECANOATE 198 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 69087-198-12 Jatenzo 12 in 1 BOX CAPSULE, LIQUID FILLED 12 12 69087-198-12 Jatenzo 120 in 1 BOTTLE, PLASTIC CAPSULE, LIQUID FILLED 120 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 69087-198 JATENZO (TESTOSTERONE UNDECANOATE) CAPSULE, LIQUID FILLED [TOLMAR INC.] 8 Current NDC, Legacy NDC, 2 package rows 20250522_ed7b5d41-7475-4c10-99b9-b62b3434ae60.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 69087-198-12 69087019812 120 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (69087-198-12) 2019-08-01 0000-00-00 No No Current